10-Q:季度报表
NT 10-Q:季报延迟披露公告
10-K:年度报表
Hepion Pharmaceuticals | NT 10-K:其他
Hepion Pharmaceuticals | 4:持股变动声明-董事 Purcell Michael J.
Hepion Pharmaceuticals | 3:首次持股声明-董事 Purcell Michael J.
Hepion Pharmaceuticals | 8-K:重大事件
Hepion Pharmaceuticals | 4:持股变动声明-董事 Block Timothy M.
Hepion Pharmaceuticals | 4:持股变动声明-董事 JACOB GARY S
Hepion Pharmaceuticals | 4:持股变动声明-董事 Lbiati Kaouthar
Hepion Pharmaceuticals | 4:持股变动声明-高管 BRANCACCIO JOHN P
Hepion Pharmaceuticals | 8-K:重大事件
Hepion Pharmaceuticals | 8-K:重大事件
Hepion Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(8.67%),Steven Boyd(8.67%)
Hepion Pharmaceuticals | 8-K:重大事件
Hepion Pharmaceuticals | 8-K:重大事件
Hepion Pharmaceuticals | 8-K:重大事件
Hepion Pharmaceuticals | 4:持股变动声明-董事 Wijngaard Peter
Hepion Pharmaceuticals:2023财年三季报
Hepion Pharmaceuticals | NT 10-Q:季报延迟披露公告
暂无数据